Aeterna Zentaris
AEZS
#10804
Rank
C$24.72 M
Marketcap
C$8.08
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

Operating Margin for Aeterna Zentaris (AEZS)

Operating Margin as of November 2026 (TTM): -87.72%

According to Aeterna Zentaris's latest financial reports and stock price the company's current Operating Margin is -87.72%. At the end of 2021 the company had an Operating Margin of -161.16%.

Operating Margin history for Aeterna Zentaris from 2001 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-161.16%24.61%
2020-129.33%-88.96%
2019-1,171.05%-3365.8%
201835.86%-101.63%
2017-2,196.64%-19.82%
2016-2,739.74%-70.27%
2015-9,216.15%-94.06%
2014-155,236.36%35090.33%
2013-441.13%627.55%
2012-60.63%-15.8%
2011-72.01%-14.08%
2010-83.81%114.36%
2009-39.10%-74.35%
2008-152.40%88.58%
2007-80.82%53.24%
2006-52.74%-2287.19%
20052.41%-40.43%
20044.05%-136.32%
2003-11.14%-38%
2002-17.97%-46.99%
2001-33.91%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Novartis
NVS
22.03%-125.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
13.21%-115.06%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
22.64%-125.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-109.76% 25.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
35.06%-139.97%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.